Biosimilars

This target graph demonstrates how much opportunity exists in biosimilars, even for competitors entering late, particularly for those who can leverage local or regional competitive advantages:

Demonstration of biosimilarity is a critical part of these projects.  Sandpiper Pharma has extensive experience in production of biosimilar products in mammalian cells and in microbial systems.

*

Experience

Sandpiper Pharma has experience with design of manufacturing processes for biosimilar products:  patent application 20200207823